Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use

J Oncol Pharm Pract. 2022 Oct;28(7):1654-1658. doi: 10.1177/10781552221077641. Epub 2022 Mar 7.

Authors

Palash Asawa¹, Zena Chahine², Urwat Vusqa¹, Yazan Samhouri³, Salman Fazal³

Affiliations

¹ Department of Internal Medicine, 6596Allegheny Health Network, Pittsburgh PA.
² Department of Hematology and Oncology, 4530University of Kentucky, Lexington, KY.
³ Division of Hematology and Cellular Therapy, 6596Allegheny Health Network Cancer Institute, Pittsburgh PA.

PMID: 35253502
DOI: 10.1177/10781552221077641

No abstract available

MeSH terms

Adenine / adverse effects
Adenine / analogs & derivatives
Aspergillosis* / drug therapy
Humans
Invasive Fungal Infections*
Piperidines / adverse effects
Spleen

Substances

Piperidines
ibrutinib
Adenine